COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Application of DOE (Design of Experiments) to Antibody Drug Conjugates (ADC) Process Development

07 May 2021

One Factor at a Time: Supporting ADC Process Characterization & Product Specification

01 Nov 2020

Manufacturing of Highly Potent Sterile Parenterals – Mobile Isolator Based Technology

16 Sep 2020

A Knowledge sharing webinar with McKinsey

13 Aug 2020

Enhancing Bio Availability when developing oral solid formulations

07 Aug 2020

Biocatalysis: Doing Difficult Chemistry by Harnessing Biology

24 Jan 2018